SMTL ID : 3o95.3 (2 other biounits)

Crystal Structure of Human DPP4 Bound to TAK-100

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.85 Å

Oligo State

homo-dimer

Ligands

1 x NAG- NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-NAG.1: 5 residues within 4Å: Chain A: I.168, N.203, T.205, E.206, K.241 No protein-ligand interaction detected (PLIP)

1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.2: 6 residues within 4Å: Chain B: I.168, Q.201, N.203, T.205, E.206, K.241 No protein-ligand interaction detected (PLIP)

7 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.3: 3 residues within 4Å: Chain A: R.121, I.122, N.124 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:N.124 Water bridges: A:R.121 NAG.4: 2 residues within 4Å: Chain A: W.161, N.255 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:N.255 NAG.5: 2 residues within 4Å: Chain A: I.293, N.295 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:N.295, A:R.570 NAG.7: 1 residues within 4Å: Chain B: N.124 2 PLIP interactions: 2 interactions with chain B Water bridges: B:N.124, B:N.124 NAG.8: 4 residues within 4Å: Chain B: N.193, T.195, Q.282, E.283 4 PLIP interactions: 4 interactions with chain B Hydrogen bonds: B:N.193, B:E.283, B:E.283 Water bridges: B:T.195 NAG.9: 2 residues within 4Å: Chain B: W.161, N.255 2 PLIP interactions: 2 interactions with chain B Water bridges: B:N.255, B:N.255 NAG.10: 4 residues within 4Å: Chain B: L.493, N.494, F.498, R.555 1 PLIP interactions: 1 interactions with chain B Water bridges: B:D.579

2 x 01T: [5-(aminomethyl)-6-(2,2-dimethylpropyl)-2-ethyl-4-(4-methylphenyl)pyridin-3-yl]acetic acid(Non-covalent)

01T.6: 13 residues within 4Å: Chain A: R.99, E.179, E.180, S.183, F.331, Y.521, S.604, Y.605, V.630, Y.636, Y.640, V.685, H.714 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:F.331, A:V.630, A:Y.636, A:V.685 Hydrogen bonds: A:E.180, A:S.604 Salt bridges: A:R.99, A:H.714 pi-Stacking: A:Y.640 pi-Cation interactions: A:R.99 01T.11: 12 residues within 4Å: Chain B: R.99, E.179, E.180, S.183, F.331, Y.521, S.604, Y.605, V.630, Y.636, Y.640, H.714 10 PLIP interactions: 10 interactions with chain B Hydrophobic interactions: B:F.331, B:V.630, B:Y.636 Hydrogen bonds: B:E.180, B:S.604, B:Y.636 Salt bridges: B:R.99, B:H.714 pi-Stacking: B:Y.640 pi-Cation interactions: B:R.99

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Miyamoto, Y. et al., Discovery of a 3-Pyridylacetic Acid Derivative (TAK-100) as a Potent, Selective and Orally Active Dipeptidyl Peptidase IV (DPP-4) Inhibitor. J.Med.Chem. (2011)

Release Date

2011-01-26

Peptides

Dipeptidyl peptidase 4: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

B
D

Dipeptidyl peptidase 4

Related Entries With Identical Sequence